Page last updated: 2024-09-03

1-deazatubercidin and miltefosine

1-deazatubercidin has been researched along with miltefosine in 1 studies

*miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin [MeSH]

*miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin [MeSH]

Compound Research Comparison

Studies
(1-deazatubercidin)
Trials
(1-deazatubercidin)
Recent Studies (post-2010)
(1-deazatubercidin)
Studies
(miltefosine)
Trials
(miltefosine)
Recent Studies (post-2010) (miltefosine)
5021,33083769

Protein Interaction Comparison

ProteinTaxonomy1-deazatubercidin (IC50)miltefosine (IC50)
RAC-alpha serine/threonine-protein kinaseHomo sapiens (human)9.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Caljon, G; de Oliveira, GM; Donola Girão, R; Hulpia, F; Jaén Batista, DDG; Karalic, I; Lin, C; Maes, L; Mazzeti, AL; Soeiro, MNC; Van Calenbergh, S1

Other Studies

1 other study(ies) available for 1-deazatubercidin and miltefosine

ArticleYear
N
    European journal of medicinal chemistry, 2022, Mar-05, Volume: 231

    Topics: Animals; Chagas Disease; Leishmania; Mice; Nucleosides; Purines; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi

2022